• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

May 1 is glaucoma prize deadline

Article

May 1 is the nomination deadline for the New York Academy of Medicine Lewis Rudin Glaucoma Prize.

New York City-May 1 is the nomination deadline for the New York Academy of Medicine (NYAM) Lewis Rudin Glaucoma Prize.

The $50,000 award recognizes a scholarly article about glaucoma published in a peer-reviewed journal within the previous calendar year and deemed most outstanding. Nominees must be the first or last author of the published work and must hold primary responsibility for the research.

The prize was established in 1995 in honor of a New York City real estate developer. It is funded by the May and Samuel Rudin Family Foundation with additional support from Jack Rudin.

For more information and to apply for the award, visit www.nyam.org/grants/rudin-glaucoma.html.

The NYAM will announce the winner in July.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.